Your first visit at Delhi Derma Clinic

The clinic is at Basement, D-48, D Block, East of Kailash, New Delhi 110065. The address sits within the residential D Block. Patients are encouraged to allow comfortable buffer time for the visit rather than scheduling tight back-to-back commitments around it. The framework does not embed specific door-to-door travel-time figures because actual travel depends on the patient's starting point and time of day.

On arrival, the patient is greeted at reception, the booking is confirmed, any patient-side documentation is checked, and a brief patient-information form is shared if the patient has not completed one in advance. The framework treats this stage as orientation rather than as data-collection-for-marketing; the information collected is for the clinical record. The patient is then routed to the consultation room when the dermatologist is ready.

A typical first-visit dermatology consultation runs around thirty-to-forty-five minutes. Complex multi-concern presentations and visits with extensive prior treatment history may run longer; routine follow-up visits within an active pathway are shorter. Patients should plan adequate time at the visit rather than scheduling immediately before another commitment.

Slot timings are honoured as closely as visit-flow allows. Selected complex visits ahead of the patient's slot may extend marginally; the framework does not run patient-flow on aggressive overbooking that creates significant wait. Where a meaningful delay is anticipated, the clinic reception communicates it. The framework treats wait-time as something to manage well rather than to ignore.

The waiting space is set up for patient comfort with seating and water available. The framework does not embed specific upsell-display flows in the waiting area; the consultation conversation is where the case-specific recommendation is arrived at rather than the corridor or the waiting bench. Patients with mobility or comfort needs can flag them at the booking conversation so accommodations are arranged.

The conversation opens with history-taking around the presenting concern — onset, trajectory, prior treatment history, current medications and supplements, relevant systemic context, family pattern where applicable, lifestyle context, and the patient's questions. The dermatologist then proceeds to examination of the relevant area or areas. Where the pathway warrants it, photographic baseline establishment follows. The visit closes with the calibrated written plan that the patient leaves with.

Question patterns typically cover the timeline of the concern, prior pathway responses, current and prior medication exposure, allergy history, hormonal-axis context where relevant, family-history context, occupation and lifestyle factors that interact with the dermatology presentation, and the patient's own goal-setting around the pathway. The framework treats history as a substantive part of the assessment rather than as a paperwork hurdle, and a thorough history often informs the recommendation as much as the examination.

Examination is calibrated to the presenting concern. For facial concerns the examination includes the relevant zones under appropriate lighting, sometimes with magnification or specialised tools (dermoscope, Wood's lamp, or scalp-analyser for selected cases). For body and hair-loss assessments the relevant zone is examined in a dignified clinical setting. The framework treats examination as a calibrated clinical step rather than as a scripted display.

Sensitive presentations — selected pigmentation patterns, hair-fall in younger patients, body-image-linked concerns, intimate-area dermatology — are handled with the appropriate clinical sensitivity. The consultation is conducted in private, with the patient's comfort and dignity prioritised. Patients can flag sensitivity preferences at the booking conversation; the framework treats patient comfort as substantive rather than as an afterthought.

Yes. Multi-concern visits are common — for example acne plus pigmentation plus hair-fall, or anti-ageing plus melasma plus body-contouring questions. The visit-length is calibrated for multi-concern complexity at the booking conversation. The framework prioritises the most pressing concern first and routes secondary concerns through the same written plan structure with calibrated timing.

Many dermatology pathways change gradually across months. Without an objective baseline, both clinician and patient struggle to judge progress accurately, because human visual memory drifts. A calibrated photographic baseline at the start of the pathway provides the comparison reference for progress assessment. The medical photography page documents the framework in full.

No. Photography is calibrated to the pathway. Pathways where progress tracking matters (acne and acne-scar pathways, melasma and pigmentation, hair-fall and hair-restoration pathways, ageing-trajectory pathways, selected lesion-monitoring contexts) typically include a baseline. Pathways where progress is largely subjective or one-time do not. No capture happens without the patient being informed and consenting at that moment.

Default use is clinical-record-only, supporting the patient's own care and the clinical conversation at follow-up. Marketing or educational use requires its own consent process with clearly framed scope. The framework keeps the default narrow rather than asking patients to opt-out of broad blanket consent. Patient images are stored under the patient-records framework rather than in personal-device albums; access is limited to the clinical team involved in care.

Yes. Patients who prefer not to be photographed are accommodated as far as is consistent with safe clinical practice. Where the pathway depends on baseline photography for sensible progress monitoring (for example certain hair-restoration pathways) the framework discusses the trade-off honestly rather than pressuring the patient into consent. The formal Patient Consent and Photography Policy in the policies section carries the binding text.

Yes. Selfies or older album photographs at known dates can help with trajectory mapping for hair-fall, pigmentation, and ageing-related concerns. The framework welcomes these where the patient has them. Patients without pre-visit photographs are not at a disadvantage; the clinic-captured baseline at the visit is a sufficient starting point.

Inside the written plan the patient finds: the calibrated recommendation, the rationale connecting assessment and recommendation, the realistic outcome range across an evidence-based timeline, the maintenance pattern where it applies, the residual-risk profile, the per-component pricing for the recommended pathway, the proposed follow-up cadence, and any blood-work or referral routing. The framework treats the written plan as part of patient-facing transparency rather than as an optional handout.

Outcomes in dermatology vary by pathway, skin context, prior history, and the patient's adherence to the pathway. Listing a single absolute outcome number on the plan would mis-set expectations. The realistic outcome range is calibrated against the evidence base for the pathway and the specific context of the patient's case, and the residual-risk profile sits alongside it rather than being hidden as a footnote.

Yes. The framework explicitly avoids "you must book your treatment today" sales pressure. Most patients leave the first visit with the written plan and time to consider it. Patients can return to discuss specific elements, can defer the recommended pathway, or can choose not to proceed; the consultation has already produced calibrated value through the assessment regardless of subsequent booking.

Second opinions are a normal part of patient decision-making and the framework supports them. The consultation summary and any photographic documentation can typically be made available to the patient for their reference at another consultation. The framework treats second-opinion-seeking as patient-supportive rather than as challenging.

Yes. The written plan is the patient's document and the framework expects that selected decisions involve family conversation — particularly for younger patients, for substantial procedural commitments, or where family-context input is part of how the patient decides. The clinic does not pressure family-private conversation into a same-day decision.

On the patient's decision to proceed, the next visit is scheduled per the calibrated pathway. For procedural pathways the next visit may be a procedural session itself if pre-procedure preparation is in place; for selected pathways the next visit is a structured procedural-day visit with its own preparation and consent process. The framework moves at the patient's pace rather than forcing a fixed booking-day-onwards cadence.

Follow-up cadence is part of the written plan. Procedural pathways are typically reviewed at the relevant response window (three-to-six months). Maintenance pathways for hair-loss, pigmentation, and ageing trajectory run six-monthly to annually. Selected medical-dermatology pathways have their own review pattern. Selected follow-ups can be supported by video format where in-person examination is not necessary.

Patients with questions during an active pathway are encouraged to use the formal channel the clinic operates around active patient queries. The framework welcomes patient questions as part of the care continuum rather than as inconvenience. For prospective patients the consultation visit is the right route for substantive medical questions, since individual case decisions warrant the full consultation context.

Under the Patient Privacy and Records Policy, patient health information is governed as confidential, access-controlled material within the framework. Access sits with the dermatologist and the trained clinical-team members directly involved in the patient's care. External marketing parties do not receive patient information through the framework absent explicit consent. Storage, access, and retention mechanics are documented in the formal privacy policy.

The framework adjusts when the pathway turns out not to fit — whether early-response review suggests a different course, the patient's context shifts, or the assessment itself evolves. Pathway-affecting and cost-affecting calibration changes are surfaced and agreed before they go ahead. A revised plan is the response when the original recommendation no longer fits — the framework does not hold the patient to the prior plan as a sunk-cost commitment.